ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 157 filers reported holding ASCENDIS PHARMA A/S in Q2 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $12,387,097 | -6.7% | 138,791 | +12.1% | 0.48% | -4.0% |
| Q1 2023 | $13,272,871 | -12.2% | 123,791 | 0.0% | 0.50% | -11.6% |
| Q4 2022 | $15,118,595 | +116.0% | 123,791 | +82.6% | 0.57% | +99.0% |
| Q3 2022 | $7,000,000 | +11.1% | 67,794 | 0.0% | 0.29% | +15.7% |
| Q2 2022 | $6,302,000 | -20.8% | 67,794 | 0.0% | 0.25% | -11.1% |
| Q1 2022 | $7,956,000 | -12.8% | 67,794 | 0.0% | 0.28% | -4.8% |
| Q4 2021 | $9,120,000 | -15.6% | 67,794 | 0.0% | 0.29% | -15.8% |
| Q3 2021 | $10,806,000 | -46.5% | 67,794 | -55.9% | 0.35% | -47.0% |
| Q2 2021 | $20,211,000 | +32.5% | 153,636 | +29.8% | 0.66% | +25.1% |
| Q1 2021 | $15,251,000 | -5.0% | 118,336 | +23.0% | 0.52% | -6.9% |
| Q4 2020 | $16,052,000 | -17.3% | 96,246 | -23.5% | 0.56% | -22.4% |
| Q3 2020 | $19,405,000 | +128.2% | 125,746 | +118.8% | 0.73% | +124.4% |
| Q2 2020 | $8,502,000 | +8.9% | 57,482 | -17.1% | 0.32% | -8.2% |
| Q1 2020 | $7,807,000 | -19.1% | 69,332 | 0.0% | 0.35% | -3.3% |
| Q4 2019 | $9,645,000 | +29.8% | 69,332 | -10.2% | 0.36% | +12.7% |
| Q3 2019 | $7,433,000 | -12.3% | 77,167 | +4.8% | 0.32% | -6.4% |
| Q2 2019 | $8,480,000 | +17.4% | 73,647 | +20.0% | 0.35% | +18.1% |
| Q1 2019 | $7,222,000 | +171.9% | 61,360 | +44.7% | 0.29% | +157.0% |
| Q4 2018 | $2,656,000 | -43.0% | 42,399 | -35.5% | 0.11% | -32.5% |
| Q3 2018 | $4,656,000 | +59.4% | 65,714 | +49.6% | 0.17% | +52.3% |
| Q2 2018 | $2,921,000 | +619.5% | 43,914 | +606.7% | 0.11% | +593.8% |
| Q1 2018 | $406,000 | – | 6,214 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 1,797,745 | $265,886,000 | 19.06% |
| RA Capital Management | 4,914,955 | $726,922,000 | 14.16% |
| Sofinnova Investments, Inc. | 1,109,874 | $164,150,000 | 10.35% |
| Eventide Asset Management | 1,709,848 | $252,887,000 | 5.50% |
| Asymmetry Capital Management, L.P. | 47,599 | $7,040,000 | 5.39% |
| BERYLSON CAPITAL PARTNERS, LLC | 58,200 | $8,608,000 | 5.30% |
| Avoro Capital Advisors LLC | 1,750,000 | $258,825,000 | 5.12% |
| Eversept Partners, LP | 220,344 | $32,588,878 | 4.47% |
| Spyglass Capital Management LLC | 452,104 | $66,866,000 | 4.14% |
| Orbimed Advisors | 1,562,986 | $231,166,000 | 3.25% |